Encoded Therapeutics Inc. is a biotechnology company advancing precision medicines for genetic disorders through genomics-driven discovery and viral gene therapy approaches. The company focuses on delivering life-changing advances for individuals with genetic disorders that are not addressable with current therapeutic approaches. Their clinical pipeline includes programs targeting Dravet syndrome and chronic neuropathic pain, with lead candidates ETX301 and ETX101 in clinical development. The company operates across multiple stages of the drug development lifecycle, from early-stage programs through later-phase clinical trials.
Beta · Sourced from candidate reports
Be the first to share your experience with Encoded Therapeutics.
Your reply helps other candidates know what to expect.
